{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:12:44Z","timestamp":1773763964935,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T00:00:00Z","timestamp":1338422400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1186\/bcr3178","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T22:22:17Z","timestamp":1354746137000},"source":"Crossref","is-referenced-by-count":54,"title":["Vitamin D and the mammary gland: a review on its role in normal development and breast cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Nair","family":"Lopes","sequence":"first","affiliation":[]},{"given":"Joana","family":"Paredes","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Luis","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Bauke","family":"Ylstra","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,5,31]]},"reference":[{"key":"2987_CR1","doi-asserted-by":"crossref","first-page":"1678S","DOI":"10.1093\/ajcn\/80.6.1678S","volume":"80","author":"MF Holick","year":"2004","unstructured":"Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004, 80: 1678S-1688S.","journal-title":"Am J Clin Nutr"},{"key":"2987_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1359\/jbmr.1998.13.3.325","volume":"13","author":"MR Haussler","year":"1998","unstructured":"Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW: The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998, 13: 325-349.","journal-title":"J Bone Miner Res"},{"key":"2987_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.3283939","volume":"240","author":"RM Evans","year":"1988","unstructured":"Evans RM: The steroid and thyroid hormone receptor superfamily. Science. 1988, 240: 889-895.","journal-title":"Science"},{"key":"2987_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/1471-2164-10-499","volume":"10","author":"JL Costa","year":"2009","unstructured":"Costa JL, Eijk PP, van de Wiel MA, ten Berge D, Schmitt F, Narvaez CJ, Welsh J, Ylstra B: Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down. BMC Genomics. 2009, 10: 499-","journal-title":"BMC Genomics"},{"key":"2987_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrc2196","volume":"7","author":"KK Deeb","year":"2007","unstructured":"Deeb KK, Trump DL, Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007, 7: 684-700.","journal-title":"Nat Rev Cancer"},{"key":"2987_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1006\/bbrc.1994.1714","volume":"201","author":"MC Dormanen","year":"1994","unstructured":"Dormanen MC, Bishop JE, Hammond MW, Okamura WH, Nemere I, Norman AW: Nonnuclear effects of the steroid hormone 1 alpha,25(OH)2-vitamin D3: analogs are able to functionally differentiate between nuclear and membrane receptors. Biochem Biophys Res Commun. 1994, 201: 394-401.","journal-title":"Biochem Biophys Res Commun"},{"key":"2987_CR7","doi-asserted-by":"crossref","first-page":"20022","DOI":"10.1016\/S0021-9258(20)80689-9","volume":"268","author":"AW Norman","year":"1993","unstructured":"Norman AW, Bouillon R, Farach-Carson MC, Bishop JE, Zhou LX, Nemere I, Zhao J, Muralidharan KR, Okamura WH: Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. J Biol Chem. 1993, 268: 20022-20030.","journal-title":"J Biol Chem"},{"key":"2987_CR8","doi-asserted-by":"crossref","first-page":"23750","DOI":"10.1016\/S0021-9258(17)31579-X","volume":"269","author":"I Nemere","year":"1994","unstructured":"Nemere I, Dormanen MC, Hammond MW, Okamura WH, Norman AW: Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J Biol Chem. 1994, 269: 23750-23756.","journal-title":"J Biol Chem"},{"key":"2987_CR9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1073\/pnas.0305802101","volume":"101","author":"LP Zanello","year":"2004","unstructured":"Zanello LP, Norman AW: Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA. 2004, 101: 1589-1594.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2987_CR10","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1210\/me.2004-0116","volume":"18","author":"JA Huhtakangas","year":"2004","unstructured":"Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW: The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol. 2004, 18: 2660-2671.","journal-title":"Mol Endocrinol"},{"key":"2987_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/CEJ.0b013e32832f9bb1","volume":"18","author":"H van der Rhee","year":"2009","unstructured":"van der Rhee H, Coebergh JW, de Vries E: Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev. 2009, 18: 458-75.","journal-title":"Eur J Cancer Prev"},{"key":"2987_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1017\/S1368980099000385","volume":"2","author":"EC Janowsky","year":"1999","unstructured":"Janowsky EC, Lester GE, Weinberg CR, Millikan RC, Schildkraut JM, Garrett PA, Hulka BS: Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr. 1999, 2: 283-291.","journal-title":"Public Health Nutr"},{"key":"2987_CR13","first-page":"118","volume":"82","author":"EB Mawer","year":"1997","unstructured":"Mawer EB, Walls J, Howell A, Davies M, Ratcliffe WA, Bundred NJ: Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab. 1997, 82: 118-122.","journal-title":"J Clin Endocrinol Metab"},{"key":"2987_CR14","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1158\/1055-9965.EPI-04-0722","volume":"14","author":"ER Bertone-Johnson","year":"2005","unstructured":"Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE: Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1991-1997.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2987_CR15","volume-title":"Ann Surg Oncol","author":"LJ Peppone","year":"2012","unstructured":"Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR, Skinner KA: The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels. Ann Surg Oncol. 2012"},{"key":"2987_CR16","doi-asserted-by":"publisher","first-page":"8390","DOI":"10.4076\/1757-1626-2-8390","volume":"2","author":"C Rainville","year":"2009","unstructured":"Rainville C, Khan Y, Tisman G: Triple negative breast cancer patients presenting with low serum vitamin D levels: a case series. Cases J. 2009, 2: 8390-","journal-title":"Cases J"},{"key":"2987_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1158\/1055-9965.EPI-11-0089","volume":"20","author":"L Peppone","year":"2011","unstructured":"Peppone L, Rickles A, Huston A, Sprod L, Hicks D, Mustian K, Skinner K: The association between prognostic demographic and tumor characteristics of breast carcinomas with serum 25-OH vitamin D levels. Cancer Epidemiol Biomarkers Prev. 2011, 20: 717-","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2987_CR18","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3945\/ajcn.2009.28869","volume":"91","author":"LN Anderson","year":"2010","unstructured":"Anderson LN, Cotterchio M, Vieth R, Knight JA: Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr. 2010, 91: 1699-1707.","journal-title":"Am J Clin Nutr"},{"key":"2987_CR19","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/jnci\/djn360","volume":"100","author":"RT Chlebowski","year":"2008","unstructured":"Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA, Women's Health Initiative Investigators: Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008, 100: 1581-1591.","journal-title":"J Natl Cancer Inst"},{"key":"2987_CR20","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1186\/bcr2880","volume":"13","author":"AH Eliassen","year":"2011","unstructured":"Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett WC, Hankinson SE: Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res. 2011, 13: R50-","journal-title":"Breast Cancer Res"},{"key":"2987_CR21","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/bcr2356","volume":"11","author":"ML McCullough","year":"2009","unstructured":"McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, Gapstur SM, Thun MJ, Calle EE: Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res. 2009, 11: R64-","journal-title":"Breast Cancer Res"},{"key":"2987_CR22","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/carcin\/23.12.2103","volume":"23","author":"GM Zinser","year":"2002","unstructured":"Zinser GM, Sundberg JP, Welsh J: Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis. 2002, 23: 2103-2109.","journal-title":"Carcinogenesis"},{"key":"2987_CR23","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1242\/dev.129.13.3067","volume":"129","author":"G Zinser","year":"2002","unstructured":"Zinser G, Packman K, Welsh J: Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development. 2002, 129: 3067-3076.","journal-title":"Development"},{"key":"2987_CR24","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1210\/me.2003-0469","volume":"18","author":"GM Zinser","year":"2004","unstructured":"Zinser GM, Welsh J: Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Mol Endocrinol. 2004, 18: 2208-2223.","journal-title":"Mol Endocrinol"},{"key":"2987_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1210\/jcem-67-3-607","volume":"67","author":"U Berger","year":"1988","unstructured":"Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW, Coombes RC: Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 1988, 67: 607-613.","journal-title":"J Clin Endocrinol Metab"},{"key":"2987_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/1471-2407-10-483","volume":"10","author":"N Lopes","year":"2010","unstructured":"Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F: Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer. 2010, 10: 483-","journal-title":"BMC Cancer"},{"key":"2987_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jsbmb.2006.04.009","volume":"100","author":"EC de Lyra","year":"2006","unstructured":"de Lyra EC, da Silva IA, Katayama ML, Brentani MM, Nonogaki S, Goes JC, Folgueira MA: 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and vitamin D receptor in women with and without breast cancer. J Steroid Biochem Mol Biol. 2006, 100: 184-192.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2987_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-3-642-55580-0_17","volume":"164","author":"M Friedrich","year":"2003","unstructured":"Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W, Reichrath J: Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res. 2003, 164: 239-246.","journal-title":"Recent Results Cancer Res"},{"key":"2987_CR29","doi-asserted-by":"publisher","first-page":"R980","DOI":"10.1186\/bcr1332","volume":"7","author":"U Segersten","year":"2005","unstructured":"Segersten U, Holm PK, Bjorklund P, Hessman O, Nordgren H, Binderup L, Akerstrom G, Hellman P, Westin G: 25-Hydroxyvitamin D3 1alphahydroxylase expression in breast cancer and use of non-1alphahydroxylated vitamin D analogue. Breast Cancer Res. 2005, 7: R980-986.","journal-title":"Breast Cancer Res"},{"key":"2987_CR30","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1158\/1078-0432.CCR-04-2359","volume":"11","author":"K Townsend","year":"2005","unstructured":"Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, Campbell MJ, Hewison M: Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res. 2005, 11: 3579-3586.","journal-title":"Clin Cancer Res"},{"key":"2987_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2559.2010.03568.x","volume":"57","author":"MA Lopez-Garcia","year":"2010","unstructured":"Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchio C, Reis-Filho JS: Breast cancer precursors revisited: molecular features and progression pathways. Histopathology. 2010, 57: 171-192.","journal-title":"Histopathology"},{"key":"2987_CR32","first-page":"1370","volume":"15","author":"SS Jensen","year":"2001","unstructured":"Jensen SS, Madsen MW, Lukas J, Binderup L, Bartek J: Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol. 2001, 15: 1370-1380.","journal-title":"Mol Endocrinol"},{"key":"2987_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0303-7207(98)00117-8","volume":"142","author":"L Verlinden","year":"1998","unstructured":"Verlinden L, Verstuyf A, Convents R, Marcelis S, Van Camp M, Bouillon R: Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol Cell Endocrinol. 1998, 142: 57-65.","journal-title":"Mol Cell Endocrinol"},{"key":"2987_CR34","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.onc.1201329","volume":"15","author":"G Wu","year":"1997","unstructured":"Wu G, Fan RS, Li W, Ko TC, Brattain MG: Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells. Oncogene. 1997, 15: 1555-1563.","journal-title":"Oncogene"},{"key":"2987_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00001813-199304000-00012","volume":"4","author":"DE Saunders","year":"1993","unstructured":"Saunders DE, Christensen C, Wappler NL, Schultz JF, Lawrence WD, Malviya VK, Malone JM, Deppe G: Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone. Anticancer Drugs. 1993, 4: 201-208.","journal-title":"Anticancer Drugs"},{"key":"2987_CR36","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1074\/jbc.M803602200","volume":"284","author":"P Dhawan","year":"2009","unstructured":"Dhawan P, Wieder R, Christakos S: CCAAT enhancer-binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells. J Biol Chem. 2009, 284: 3086-3095.","journal-title":"J Biol Chem"},{"key":"2987_CR37","doi-asserted-by":"publisher","first-page":"e7872","DOI":"10.1371\/journal.pone.0007872","volume":"4","author":"ME Beildeck","year":"2009","unstructured":"Beildeck ME, Islam M, Shah S, Welsh J, Byers SW: Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines. PLoS One. 2009, 4: e7872-","journal-title":"PLoS One"},{"key":"2987_CR38","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1038\/sj.onc.1203888","volume":"19","author":"MJ Campbell","year":"2000","unstructured":"Campbell MJ, Gombart AF, Kwok SH, Park S, Koeffler HP: The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene. 2000, 19: 5091-5097.","journal-title":"Oncogene"},{"key":"2987_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1210\/en.2009-0855","volume":"151","author":"AV Krishnan","year":"2010","unstructured":"Krishnan AV, Swami S, Peng L, Wang J, Moreno J, Feldman D: Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology. 2010, 151: 32-42.","journal-title":"Endocrinology"},{"key":"2987_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0960-0760(96)00055-6","volume":"58","author":"M Simboli-Campbell","year":"1996","unstructured":"Simboli-Campbell M, Narvaez CJ, Tenniswood M, Welsh J: 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 1996, 58: 367-376.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2987_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ijc.11202","volume":"106","author":"GE Weitsman","year":"2003","unstructured":"Weitsman GE, Ravid A, Liberman UA, Koren R: Vitamin D enhances caspase-dependent and -independent TNFalpha-induced breast cancer cell death: The role of reactive oxygen species and mitochondria. Int J Cancer. 2003, 106: 178-186.","journal-title":"Int J Cancer"},{"key":"2987_CR42","doi-asserted-by":"publisher","first-page":"9101","DOI":"10.1074\/jbc.M006876200","volume":"276","author":"CJ Narvaez","year":"2001","unstructured":"Narvaez CJ, Welsh J: Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem. 2001, 276: 9101-9107.","journal-title":"J Biol Chem"},{"key":"2987_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.molmed.2010.04.005","volume":"16","author":"M Hoyer-Hansen","year":"2010","unstructured":"Hoyer-Hansen M, Nordbrandt SP, Jaattela M: Autophagy as a basis for the health-promoting effects of vitamin D. Trends Mol Med. 2010, 16: 295-302.","journal-title":"Trends Mol Med"},{"key":"2987_CR44","first-page":"1439","volume":"61","author":"R Koren","year":"2001","unstructured":"Koren R, Hadari-Naor I, Zuck E, Rotem C, Liberman UA, Ravid A: Vitamin D is a prooxidant in breast cancer cells. Cancer Res. 2001, 61: 1439-1444.","journal-title":"Cancer Res"},{"key":"2987_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1139\/o94-072","volume":"72","author":"J Welsh","year":"1994","unstructured":"Welsh J: Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem Cell Biol. 1994, 72: 537-545.","journal-title":"Biochem Cell Biol"},{"key":"2987_CR46","first-page":"862","volume":"59","author":"A Ravid","year":"1999","unstructured":"Ravid A, Rocker D, Machlenkin A, Rotem C, Hochman A, Kessler-Icekson G, Liberman UA, Koren R: 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res. 1999, 59: 862-867.","journal-title":"Cancer Res"},{"key":"2987_CR47","first-page":"2040","volume":"60","author":"Q Wang","year":"2000","unstructured":"Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R: 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res. 2000, 60: 2040-2048.","journal-title":"Cancer Res"},{"key":"2987_CR48","first-page":"2848","volume":"51","author":"YL Cho","year":"1991","unstructured":"Cho YL, Christensen C, Saunders DE, Lawrence WD, Deppe G, Malviya VK, Malone JM: Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells. Cancer Res. 1991, 51: 2848-2853.","journal-title":"Cancer Res"},{"key":"2987_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ccr.2009.11.025","volume":"17","author":"P Stambolsky","year":"2010","unstructured":"Stambolsky P, Tabach Y, Fontemaggi G, Weisz L, Maor-Aloni R, Siegfried Z, Shiff I, Kogan I, Shay M, Kalo E, Blandino G, Simon I, Oren M, Rotter V: Modulation of the vitamin D3 response by cancer-associated mutant p53. Cancer Cell. 2010, 17: 273-285.","journal-title":"Cancer Cell"},{"key":"2987_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01753887","volume":"12","author":"CM Hansen","year":"1994","unstructured":"Hansen CM, Frandsen TL, Brunner N, Binderup L: 1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis. 1994, 12: 195-202.","journal-title":"Clin Exp Metastasis"},{"key":"2987_CR51","first-page":"221","volume":"11","author":"K Koli","year":"2000","unstructured":"Koli K, Keski-Oja J: 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ. 2000, 11: 221-229.","journal-title":"Cell Growth Differ"},{"key":"2987_CR52","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1158\/1535-7163.MCT-06-0092","volume":"5","author":"S Sundaram","year":"2006","unstructured":"Sundaram S, Beckman MJ, Bajwa A, Wei J, Smith KM, Posner GH, Gewirtz DA: QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells. Mol Cancer Ther. 2006, 5: 2806-2814.","journal-title":"Mol Cancer Ther"},{"key":"2987_CR53","first-page":"4412","volume":"60","author":"K El Abdaimi","year":"2000","unstructured":"El Abdaimi K, Dion N, Papavasiliou V, Cardinal PE, Binderup L, Goltzman D, Ste-Marie LG, Kremer R: The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res. 2000, 60: 4412-4418.","journal-title":"Cancer Res"},{"key":"2987_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1432-0436.2006.00131.x","volume":"75","author":"N Pendas-Franco","year":"2007","unstructured":"Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, Aguilera O, Steinmeyer A, Gamallo C, Berciano MT, Lafarga M, Munoz A: Vitamin D regulates the phenotype of human breast cancer cells. Differentiation. 2007, 75: 193-207.","journal-title":"Differentiation"},{"key":"2987_CR55","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-04-0795","volume":"64","author":"J Paredes","year":"2004","unstructured":"Paredes J, Stove C, Stove V, Milanezi F, Van Marck V, Derycke L, Mareel M, Bracke M, Schmitt F: P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Res. 2004, 64: 8309-8317.","journal-title":"Cancer Res"},{"key":"2987_CR56","first-page":"249","volume":"32","author":"N Lopes","year":"2012","unstructured":"Lopes N, Carvalho J, Duraes C, Sousa B, Gomes M, Costa JL, Oliveira C, Paredes J, Schmitt F: 1Alpha,25-dihydroxyvitamin D3 Induces de novo E-cadherin Expression in Triple-negative Breast Cancer Cells by CDH1-promoter Demethylation. Anticancer Res. 2012, 32: 249-257.","journal-title":"Anticancer Res"},{"key":"2987_CR57","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0014-2999(90)90483-M","volume":"178","author":"T Oikawa","year":"1990","unstructured":"Oikawa T, Hirotani K, Ogasawara H, Katayama T, Nakamura O, Iwaguchi T, Hiragun A: Inhibition of angiogenesis by vitamin D3 analogues. Eur J Pharmacol. 1990, 178: 247-250.","journal-title":"Eur J Pharmacol"},{"key":"2987_CR58","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/01.RES.87.3.214","volume":"87","author":"DJ Mantell","year":"2000","unstructured":"Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE: 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res. 2000, 87: 214-220.","journal-title":"Circ Res"},{"key":"2987_CR59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0014-5793(98)00348-2","volume":"426","author":"JM Gonzalez-Sancho","year":"1998","unstructured":"Gonzalez-Sancho JM, Alvarez-Dolado M, Munoz A: 1,25-Dihydroxyvitamin D3 inhibits tenascin-C expression in mammary epithelial cells. FEBS Lett. 1998, 426: 225-228.","journal-title":"FEBS Lett"},{"key":"2987_CR60","first-page":"349","volume":"6","author":"H Matsumoto","year":"1999","unstructured":"Matsumoto H, Iino Y, Koibuchi Y, Andoh T, Horii Y, Takei H, Horiguchi J, Maemura M, Yokoe T, Morishita Y: Antitumor effect of 22-oxacalcitriol on estrogen receptor-negative MDA-MB-231 tumors in athymic mice. Oncol Rep. 1999, 6: 349-352.","journal-title":"Oncol Rep"},{"key":"2987_CR61","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1158\/1078-0432.CCR-11-0462","volume":"17","author":"SJ Smeets","year":"2011","unstructured":"Smeets SJ, Harjes U, van Wieringen WN, Sie D, Brakenhoff RH, Meijer GA, Ylstra B: To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!. Clin Cancer Res. 2011, 17: 4959-4964.","journal-title":"Clin Cancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr3178\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T14:11:55Z","timestamp":1643811115000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr3178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,31]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2987"],"URL":"https:\/\/doi.org\/10.1186\/bcr3178","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,31]]},"article-number":"211"}}